ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors-Reference-Cited by-同舟云学术

ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors

Published:2013-05-01 Issue:5 Volume:8 Page:e62483
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Balbás-Martínez Cristina,Rodríguez-Pinilla María,Casanova Ariel,Domínguez Orlando,Pisano David G.,Gómez Gonzalo,Lloreta Josep,Lorente José A.,Malats Núria,Real Francisco X.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference55 articles.

1. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;RJ Sylvester;Eur Urol,2006

2. Thomas F, Rosario DJ, Rubin N, Goepel JR, Abbod MF, et al.. (2012) The long-term outcome of treated high-risk nonmuscle-invasive bladder cancer: Time to change treatment paradigm? Cancer; doi: 10.1002/cncr.27587. [Epub ahead of print] PubMed PMID: 22544645.

3. Urothelial tumorigenesis: a tale of divergent pathways;XR Wu;Nat Rev Cancer,2005

4. Molecular biology of bladder cancer;NM Luis;Clin Transl Oncol,2007

5. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas;D Cappellen;Nat Genet,1999

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular biomarkers of progression in non-muscle-invasive bladder cancer — beyond conventional risk stratification;Nature Reviews Urology;2024-08-02

2. De novo variation in ARID1B gene causes Coffin-Siris syndrome 1 in a Chinese family with excessive early-onset high myopia;BMC Medical Genomics;2024-05-24

3. The Role of the AT-Rich Interaction Domain 1A Gene (ARID1A) in Human Carcinogenesis;Genes;2023-12-19

4. The somatic mutational landscape and role of the ARID1A gene in hepatocellular carcinoma;Heliyon;2023-03

5. Biological Stratification of Invasive and Advanced Urothelial Carcinoma;Urologic Clinics of North America;2023-02